SentrySciences, Inc.

About SentrySciences, Inc.

SentrySciences focuses on providing advanced solutions for contamination control and cleanroom monitoring. Through their ParticleSentry product lines, they enable customers to detect, identify, and control contamination in clean environments and drug products, ensuring high-quality production and patient safety across various industries.

Products & Services

ParticleSentryAI:Software that analyzes subvisible particle images and protein aggregates in biological drug substances using deep machine learning to detect aggregation, identify shifts in particle populations, and control critical processes for improved drug quality and patient safety.

ParticleSentryEM:A suite of premium products and services for cleanroom monitoring, including instrumentation, design, consultation, installation, and system validation, to monitor environmental parameters and resolve contamination issues.

Bioreset Max:A product for bio-decontamination with an automatic cycle mode activated by a single button press.

Particle Image Analysis:Technology for analyzing particle images in various applications.

Aerosol Particle Counters:Devices for counting aerosol particles in clean environments.

Remote Active Air Sampler:Equipment for remote air sampling in controlled environments.

Microbial Air Sampler:Tool for sampling microbial content in the air.

Rapid Microbial Detection:System for quick detection of microbial presence.

Environmental Monitoring:Solutions for monitoring environmental conditions in cleanrooms.

V-PHP/VHP Sterilization:Sterilization technology using vaporized hydrogen peroxide.

Specialties

Deep Machine Learning Protein Aggregate Analysis Environmental Monitoring Contamination Detection and Control Bio-Decontamination Cleanroom Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Early-Stage Capital and Retention Grant T: - FT: Early-Stage Capital and Retention Grant	A: 250000 MR: - FA: $250,000 FAN: 250000	D: 2023-01-05 FD: 2023-01-05	1 investors

Early-Stage Capital and Retention Grant Latest

2023-01-05

$250K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Glenn Brandon

Chief Executive Officer

E

Erik Haugen

Chief Operating Officer

D

Dan Knollenberg

Chief Financial Officer

M

Mark Berdovich

Director of Sales

S

Sandy Hutchison

Global Director of AI Software Products

M

Mark Cowley

Systems Integration Manager

View 8 more team members with Pro

Unlock Full Team Directory

Recent News